| Thomas Land, PT, DPT | |
|
617 Main Street, Carlin, NV 89822 | |
| (775) 777-1276 | |
| (775) 777-7022 |
| Full Name | Thomas Land |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 10 Years |
| Location | 617 Main Street, Carlin, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770079030 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Secondary |
| 225100000X | Physical Therapist | 4663 (Nevada) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| First Choice Physical Therapy | 8921384611 | 5 |
| Robert G Berry Jr Elko Chartered Llc | 0446573380 | 10 |
News Archive
American Medical News reports on doctors' frustrations with the Medicare program and looks at the practice of Juliette Madrigal-Dersch, an internist in Marble Falls, Texas, who "decided to see Medicare patients only on a private-contracting basis. That means neither she nor her patients can claim any payment from Medicare. It also means she can charge what her services actually cost, not just what the government says it will pay. She also can choose not to charge anything, as is her policy for patients age 90 and older."
The Centers for Disease Control's Advisory Committee on Immunization Practices recommended new treatment practices Wednesday for shingles based on a vaccine initially developed at the University of Colorado Health Sciences Center, now the University of Colorado Anschutz Medical Campus.
Watson Pharmaceuticals, Inc., today announced that it intends to launch ella® (ulipristal acetate), a novel oral emergency contraceptive, in the fourth quarter of 2010. Watson's announcement follows the approval of ella® by the FDA as safe and effective in preventing unintended pregnancy for up to 120 hours – or five days – post-unprotected intercourse (UPI) or contraceptive failure.
StemCells, Inc. (NASDAQ:STEM) announced today that it will soon initiate with the University of California, San Francisco (UCSF) Children's Hospital a Phase I clinical trial to evaluate the therapeutic potential of StemCells' proprietary HuCNS-SC® product candidate (purified human neural stem cells) to treat Pelizaeus-Merzbacher Disease (PMD), a myelination disorder that primarily affects infants and young children.
The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, pose complex challenges to the global public health, research and medical communities, write federal scientists from NIH's National Institute of Allergy and Infectious Diseases and from the Centers for Disease Control and Prevention.
› Verified 2 days ago
| Provider Name | Robert G Berry Jr Elko Chartered Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1386986206 PECOS PAC ID: 0446573380 Enrollment ID: O20141229000181 |
News Archive
American Medical News reports on doctors' frustrations with the Medicare program and looks at the practice of Juliette Madrigal-Dersch, an internist in Marble Falls, Texas, who "decided to see Medicare patients only on a private-contracting basis. That means neither she nor her patients can claim any payment from Medicare. It also means she can charge what her services actually cost, not just what the government says it will pay. She also can choose not to charge anything, as is her policy for patients age 90 and older."
The Centers for Disease Control's Advisory Committee on Immunization Practices recommended new treatment practices Wednesday for shingles based on a vaccine initially developed at the University of Colorado Health Sciences Center, now the University of Colorado Anschutz Medical Campus.
Watson Pharmaceuticals, Inc., today announced that it intends to launch ella® (ulipristal acetate), a novel oral emergency contraceptive, in the fourth quarter of 2010. Watson's announcement follows the approval of ella® by the FDA as safe and effective in preventing unintended pregnancy for up to 120 hours – or five days – post-unprotected intercourse (UPI) or contraceptive failure.
StemCells, Inc. (NASDAQ:STEM) announced today that it will soon initiate with the University of California, San Francisco (UCSF) Children's Hospital a Phase I clinical trial to evaluate the therapeutic potential of StemCells' proprietary HuCNS-SC® product candidate (purified human neural stem cells) to treat Pelizaeus-Merzbacher Disease (PMD), a myelination disorder that primarily affects infants and young children.
The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, pose complex challenges to the global public health, research and medical communities, write federal scientists from NIH's National Institute of Allergy and Infectious Diseases and from the Centers for Disease Control and Prevention.
› Verified 2 days ago
| Provider Name | First Choice Physical Therapy |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1801336169 PECOS PAC ID: 8921384611 Enrollment ID: O20170412000595 |
News Archive
American Medical News reports on doctors' frustrations with the Medicare program and looks at the practice of Juliette Madrigal-Dersch, an internist in Marble Falls, Texas, who "decided to see Medicare patients only on a private-contracting basis. That means neither she nor her patients can claim any payment from Medicare. It also means she can charge what her services actually cost, not just what the government says it will pay. She also can choose not to charge anything, as is her policy for patients age 90 and older."
The Centers for Disease Control's Advisory Committee on Immunization Practices recommended new treatment practices Wednesday for shingles based on a vaccine initially developed at the University of Colorado Health Sciences Center, now the University of Colorado Anschutz Medical Campus.
Watson Pharmaceuticals, Inc., today announced that it intends to launch ella® (ulipristal acetate), a novel oral emergency contraceptive, in the fourth quarter of 2010. Watson's announcement follows the approval of ella® by the FDA as safe and effective in preventing unintended pregnancy for up to 120 hours – or five days – post-unprotected intercourse (UPI) or contraceptive failure.
StemCells, Inc. (NASDAQ:STEM) announced today that it will soon initiate with the University of California, San Francisco (UCSF) Children's Hospital a Phase I clinical trial to evaluate the therapeutic potential of StemCells' proprietary HuCNS-SC® product candidate (purified human neural stem cells) to treat Pelizaeus-Merzbacher Disease (PMD), a myelination disorder that primarily affects infants and young children.
The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, pose complex challenges to the global public health, research and medical communities, write federal scientists from NIH's National Institute of Allergy and Infectious Diseases and from the Centers for Disease Control and Prevention.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Land, PT, DPT 248 Country Club Pkwy, Spring Creek, NV 89815-5830 Ph: (775) 777-1276 | Thomas Land, PT, DPT 617 Main Street, Carlin, NV 89822 Ph: (775) 777-1276 |
News Archive
American Medical News reports on doctors' frustrations with the Medicare program and looks at the practice of Juliette Madrigal-Dersch, an internist in Marble Falls, Texas, who "decided to see Medicare patients only on a private-contracting basis. That means neither she nor her patients can claim any payment from Medicare. It also means she can charge what her services actually cost, not just what the government says it will pay. She also can choose not to charge anything, as is her policy for patients age 90 and older."
The Centers for Disease Control's Advisory Committee on Immunization Practices recommended new treatment practices Wednesday for shingles based on a vaccine initially developed at the University of Colorado Health Sciences Center, now the University of Colorado Anschutz Medical Campus.
Watson Pharmaceuticals, Inc., today announced that it intends to launch ella® (ulipristal acetate), a novel oral emergency contraceptive, in the fourth quarter of 2010. Watson's announcement follows the approval of ella® by the FDA as safe and effective in preventing unintended pregnancy for up to 120 hours – or five days – post-unprotected intercourse (UPI) or contraceptive failure.
StemCells, Inc. (NASDAQ:STEM) announced today that it will soon initiate with the University of California, San Francisco (UCSF) Children's Hospital a Phase I clinical trial to evaluate the therapeutic potential of StemCells' proprietary HuCNS-SC® product candidate (purified human neural stem cells) to treat Pelizaeus-Merzbacher Disease (PMD), a myelination disorder that primarily affects infants and young children.
The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, pose complex challenges to the global public health, research and medical communities, write federal scientists from NIH's National Institute of Allergy and Infectious Diseases and from the Centers for Disease Control and Prevention.
› Verified 2 days ago